Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引:0
|
作者
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
关键词
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I
10.1007/s13760-021-01846-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:245 / 247
页数:3
相关论文
共 50 条
  • [31] Polymeric Complements to the Alzheimer's Disease Biomarker β-Amyloid Isoforms Aβ1-40 and Aβ1-42 for Blood Serum Analysis under Denaturing Conditions
    Urraca, Javier L.
    Aureliano, Carla S. A.
    Schillinger, Eric
    Esselmann, Hermann
    Wiltfang, Jens
    Sellergren, Boerje
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (24) : 9220 - 9223
  • [32] Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides
    Arispe, N
    Doh, M
    FASEB JOURNAL, 2002, 16 (12): : 1526 - 1536
  • [33] Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
    Nutu, Magdalena
    Zetterberg, Henrik
    Londos, Elisabet
    Minthon, Lennart
    Nagga, Katarina
    Blennow, Kaj
    Hansson, Oskar
    Ohrfelt, Annika
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 36 (1-2) : 99 - 110
  • [34] Effects of nicotine on 1-40 and 1-42 beta amyloid levels and nicotinic receptors in brains from Alzheimer's patients
    Hellström-Lindahl, E
    Mousavi, M
    Nordberg, A
    Ravid, R
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S270 - S270
  • [35] Blood plasma biomarkers for Alzheimer's disease: Aβ1-42/1-40 vs. AβX-42/X-40
    Klafki, Hans-Wolfgang
    Wirths, Oliver
    Jahn, Olaf
    Morgado, Barbara
    Esselmann, Hermann
    Wiltfang, Jens
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2024, 62 (02) : E56 - E57
  • [36] CSF Aβ1-42 Levels and Glucose Metabolism in Alzheimer's Disease
    Dumurgier, Julien
    Paquet, Claire
    Peoc'h, Katell
    Lapalus, Pauline
    Mouton-Liger, Francois
    Benisty, Sarah
    Chasseigneaux, Stephanie
    Chabriat, Hughes
    Hugon, Jacques
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (04) : 845 - 851
  • [37] Amyloid beta-protein (A beta) 1-40 but not A beta 1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in faat brain
    Shin, RW
    Ogino, K
    Kondo, A
    Saido, TC
    Trojanowski, JQ
    Kitamoto, T
    Tateishi, J
    JOURNAL OF NEUROSCIENCE, 1997, 17 (21): : 8187 - 8193
  • [38] Solid-State NMR Structural Studies of Alzheimer's Disease Aβ(1-42) And Aβ(1-40) In Phospholipid Bilayers
    Gehman, John D.
    Verardi, Raffaello
    Mehta, Anil K.
    Veglia, Gianluigi
    Separovic, Frances
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 176A - 176A
  • [39] Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease
    Thijssen, Elisabeth H.
    Verberk, Inge M. W.
    Vanbrabant, Jeroen
    Koelewijn, Anne
    Heijst, Hans
    Scheltens, Philip
    van der Flier, Wiesje
    Vanderstichele, Hugo
    Stoops, Erik
    Teunissen, Charlotte E.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [40] Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease
    Pottiez, Gwenael
    Yang, Li
    Stewart, Tessandra
    Song, Ning
    Aro, Patrick
    Galasko, Douglas R.
    Quinn, Joseph F.
    Peskind, Elaine R.
    Shi, Min
    Zhang, Jing
    JOURNAL OF PROTEOME RESEARCH, 2017, 16 (03) : 1228 - 1238